Babette’s Cancer Journey: Remarkable Progress and a Future in Sight
Babette’s journey with Immunocine is progressing steadily, and we’re excited to bring you another update on her path to recovery. Now nearly five months after completing her treatment, Babette continues to work with the Immunocine Team, who evaluate her medical reports and scans to closely to provide feedback.
Since completing her treatment, Babette’s health improvements have been remarkable. Now close to remission, Babette’s personal commitment and dedication to beating her cancer are finally near. With the most recent data and developments in hand, Babette has generously agreed to provide another update to her previous blog post.
Join us in reading Babette’s latest health update and share in her inspiring path toward complete recovery. If you are not familiar with Babette’s treatment journey, read her blog written during treatment and her other blog written right after completing treatment.
Celebrating the Power of Immunocine’s Treatment
Well folks, it’s time for me to begin celebrating in a bigger way . . . the Immunocine treatment is continuing to do what it does best!
When I started treatment, I had three tumors located throughout my pelvic area with the largest one 5.2 x 4.6 cm in size. Today, the largest tumor is completely gone. And only one of the initial three tumors remains, which is quickly dissolving. It now measures a mere 2.5 centimeters at its widest point, with 1 centimeter being normal lymph node tissue.
Just 1.5 centimeters left to go. I am so incredibly happy!!!
Not So Patiently Waiting
I won’t lie – the suspense of the last four months has been a little uncomfortable. Although my bloodwork and imaging just before leaving Cancun showed the Immunocine Dendritic Cell Treatment (IDCT) had already stopped my cancer growth, I knew I would only feel safe if the tumors were completely gone.
So while I could have left my cancer stabilized, and it would likely have disappeared over the coming year or year and a half, I knew I wanted the final results faster.
And after consulting with the Immunocine team, they also wanted the final results faster. The Immunocine Team informed me that they have recently seen accelerated results when patients pair their IDCT paired with traditional immunotherapy “checkpoint inhibitors”.
Combining Immunocine with a Checkpoint Inhibitor
As Dr. Matt Halpert explained to me, checkpoint inhibitors “are primarily designed to overcome immune exhaustion and re-power cancer-educated T-cells”. With the support of my US oncologist, I decided to do three Keytruda immunotherapy infusions, spaced three weeks apart.
In conventional cancer therapy, if Keytruda is used, people often go through 60-80 infusions – so getting results in 3 sounded like the best bargain ever!
And it was! My results are amazingly good news. After battling this cancer for four and half years, I cannot tell you how ecstatic I am to see the end in sight. I know my immune system is continuing to work on my remaining hitchhiker, so I imagine that within the near future, I will be completely cancer free with BOTH feet planted firmly again in the real world.
Stay tuned for the ultimate good news soon . . . .
READ THIS NEXT
Cancer, a word that evokes fear and uncertainty, has long been one of humanity’s most formidable adversaries. It is a complex group of diseases characterized by the uncontrollable growth and spread of abnormal cells in the body1. In this post, we will delve into the fundamentals of cancer, its interaction with the immune system, its …Read More
Cancer, a complex group of diseases characterized by uncontrolled cell growth, has been a significant challenge for medical science. Over the years, researchers have developed various tools and techniques to diagnose, monitor, and treat different types of cancers. One such tool that has gained prominence in the realm of cancer detection and management is the …Read More
The relationship between cancer and oxygen is complicated, and nothing written here is going to change that. However, an alternative treatment option sometimes revolves around the use of hyperbaric chambers and ‘oxygen-loading’ programs, and as a matter of due diligence we should dive into the scientific merit here.Read More